Biosimilars : Design and Analysis of Follow-on Biologics.

As many biological products face losing their patents in the next decade, the pharmaceutical industry needs an abbreviated regulatory pathway for approval of biosimilar drug products, which are cost-effective, follow-on/subsequent versions of the innovator's biologic products. But scientific ch...

Full description

Bibliographic Details

Online Access:	Full Text (via ProQuest)
Main Author:	Chow, Shein-Chung
Format:	eBook
Language:	English
Published:	Hoboken : CRC Press, 2013.
Series:	Chapman & Hall/CRC biostatistics series.
Subjects:	Biological products. Drugs > Generic substitution. Pharmaceutical biotechnology industry. Pharmaceutical biotechnology. Pharmaceutical policy. Biologicals.